EU licence granted for Erleada in prostate cancer
Janssen’s new treatment for prostate cancer Erleada has been licensed by the European Commission.
Read More
Tag: non-metastatic
- US study reveals interferon combinations cause lupus symptoms and affect treatment
- NIHR and TJBCM announce new funding initiative for novel brain tumour research
- UKHSA and ICL confirm variant which plays key role in global surge of Strep A infections
- Study reveals heart failure device could monitor patients and prevent hospitalisation
- MIT’s new MRI brain light-detecting technique could support brain cell studies
